Pulmonx LUNG
NASDAQ LUNG
$2.32 +0.01 (+0.22%)
As of: Aug 20, 2026 · 3:59 PM EDT

Pulmonx (LUNG) Gross Margin (2019 - 2025)

Pulmonx (LUNG) posted quarterly Gross Margin of 74.65% for Q3 2025, up 95.0% year-over-year from 38.28% in Q3 2024, and up 3.53% quarter-over-quarter from 72.11% in Q2 2025.

Pulmonx (LUNG) Gross Margin (2019 - 2025) Analysis & Trends

Pulmonx (LUNG) has reported Gross Margin for 7 consecutive years, with 74.65% the latest figure, recorded in Q3 2025.

  • In Q3 2025, Gross Margin rose 95.0% year-over-year to 74.65%; the TTM figure through Sep 2025 stood at 73.3% (down 86.0% YoY), while the FY2024 annual figure was 74.0%, up 9.0% from the prior year.
  • Gross Margin improved to 74.65% in Q3 2025 per LUNG's latest filing, from 72.11% in the prior quarter.
  • Across five years, Gross Margin topped out at 75.21% in Q1 2022 and bottomed at 71.52% in Q1 2021.
  • Historically, Gross Margin has averaged 73.79% across 5 years, with a median of 73.99% in 2021.
  • Annual changes were most pronounced in 2021 — Gross Margin surged 4644 bps — and 2023, when it tumbled 235 bps.
  • Pulmonx's Gross Margin stood at 74.78% in 2021, then slipped by 3 bps to 72.51% in 2022, then grew by 3 bps to 74.7% in 2023, then declined by 1 bps to 74.02% in 2024, then gained by 1 bps to 74.65% in 2025.
  • Business Quant data shows LUNG's Gross Margin at 74.65% in Q3 2025, 72.11% in Q2 2025, and 72.51% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 57.71%
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 68.27%
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 65.35%
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 70.71%
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 77.46%
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 63.44%
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 41.17%
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 47.38%
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 45.84%
10 Pulmonx 93.95 Mn 24.20 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 74.65%
Jun 30, 2025 72.11%
Mar 31, 2025 72.51%
Dec 31, 2024 74.02%
Sep 30, 2024 73.70%
Jun 30, 2024 73.65%
Mar 31, 2024 74.67%
Dec 31, 2023 74.70%
Sep 30, 2023 73.74%
Jun 30, 2023 74.06%
Mar 31, 2023 72.85%
Dec 31, 2022 72.51%
Sep 30, 2022 75.19%
Jun 30, 2022 74.68%
Mar 31, 2022 75.21%
Dec 31, 2021 74.78%
Sep 30, 2021 73.44%
Jun 30, 2021 73.99%
Mar 31, 2021 71.52%
Dec 31, 2020 72.00%